Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ICH To Address Postmarketing Issues As Possible Topic At May Meeting

Executive Summary

Postmarketing issues surrounding drug products will be taken up as a new topic for consideration at the May meeting of the International Conference on Harmonization Steering Committee in Tokyo.
Advertisement

Related Content

Product Safety Update Report Burden Of Analysis Is On Sponsors, FDA Says
Product Safety Update Report Burden Of Analysis Is On Sponsors, FDA Says
ICH Implementation May Sap Resources From Product Review, CBER Says
ICH Implementation May Sap Resources From Product Review, CBER Says
FDA Plans Proposed Rule To Amend Expedited Safety Reporting Regulations
FDA Plans Proposed Rule To Amend Expedited Safety Reporting Regulations
FDA Will Accept Common Technical Document Instead Of NDA In July 2001
Advertisement
UsernamePublicRestriction

Register

PS037514

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel